Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.
He G, Wan S, Wu Y, Chu Z, Shen H, Zhang S, Chen L, Bao Z, Gu S, Huang J, Huang L, Gong G, Zou Y, Zhu Q, Xu Y.
He G, et al.
J Med Chem. 2022 Nov 10;65(21):14348-14365. doi: 10.1021/acs.jmedchem.2c00263. Epub 2022 Aug 11.
J Med Chem. 2022.
PMID: 35952367